STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells <i>in vitro</i>
Vivian Wai Yan Lui(Chinese University of Hong Kong), Anthony T.�C. Chan(Chinese University of Hong Kong)
Cited by 70
Related Papers
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
|Journal of Clinical Oncology|2021|393
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling
|Life Science Alliance|2020|60
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
|Investigational New Drugs|2009|44
Barriers to clinical trial recruitment in head and neck cancer
|Oral Oncology|2015|40